<DOC>
	<DOCNO>NCT02344160</DOCNO>
	<brief_summary>The objective study demonstrate non-inferiority stem revision rate subject implant REDAPT™ System revision rate le 9.8 % 5 year mark assume observed rate 6.5 % 5 year . Additional data collect outcome safety effectiveness data 10 year post REDAPT revision surgery .</brief_summary>
	<brief_title>REDAPT Revision System Study Assess 5 Year Revision Rate &amp; 10 Year Revision Rate Safety Effectiveness</brief_title>
	<detailed_description>This study prospective , multi-center , consecutive series study subject treat REDAPT™ . The safety effectiveness REDAPT™ revision stem assess maximum 5 year additional follow 10 year assess outcomes . The objective study establish REDAPT™ stem revision rate le 9.8 % 5 year observed rate literature review 6.5 % 5 year .</detailed_description>
	<criteria>Subject require revision hip arthroplasty Subject require subsequent revision joint replacement involve insertion , removal and/or replacement prosthesis implant Subjects inflammatory degenerative joint disease include rheumatoid arthritis , arthritis secondary variety disease anomaly , congenital dysplasia ; noninflammatory degenerative joint disease ( NIDJD ) composite diagnosis osteoarthritis , avascular necrosis , traumatic arthritis , slip capital epiphysis , fuse hip , fracture pelvis , diastrophic variant Treatments nonunion , femoral neck fracture trochanteric fracture proximal femur head involvement unmanageable use technique Endoprosthesis , femoral osteotomy , Girdlestone resection Subject least 18 year age Subject skeletally mature Investigators judgment Subject willing consent participate study Subject stable health free treat stabilized cardiac , pulmonary , hematological , infection , condition would pose excessive operative risk Known allergies component device Subject enter another investigational drug , biologic , device study within 30 day active study participation Subject know risk lose followup , failure return schedule visit Subject face current impending incarceration Female subject childbearing age use approve method contraception Mental neurological condition could impair subject 's ability willingness comply study Physical condition activity tend place extreme load implant , e.g. , Charcot joint , muscle deficiency , multiple joint disability , etc . Skeletal immaturity Subject severely overweight ( BMI &gt; 40 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Total Hip Arthroplasty</keyword>
	<keyword>THA</keyword>
</DOC>